Cardiac Safety Profile of Imatinib and Nilotinib In Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Results From ENESTnd.

被引：0

作者：

Larson, Richard A. ^{[1
]}

Hochhaus, Andreas ^{[2
]}

Saglio, Giuseppe ^{[3
]}

Rosti, Gianantonio ^{[4
]}

Lopez, Jose L. ^{[5
]}

Stenke, Leif ^{[6
,7
]}

Nakamae, Hirohisa ^{[8
]}

Goldberg, Stuart L. ^{[9
]}

Wang, Ming-Chung ^{[10
]}

Gallagher, Neil J. ^{[11
]}

Hoenekopp, Albert ^{[11
]}

Ortmann, Christine-Elke

Hughes, Timothy P. ^{[12
]}

Kantarjian, Hagop M. ^{[13
]}

机构：

[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[2] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany

[3] Univ Turin, Div Internal Med & Hematol, Orbassano, Italy

[4] Univ Bologna, Dept Hematol Oncol, Bologna, Italy

[5] Banco Municipal Sangre, Dpt Clin Hematol, Caracas, Venezuela

[6] Karolinska Univ Hosp, Div Hematol, Stockholm, Sweden

[7] Karolinska Inst, Stockholm, Sweden

[8] Osaka City Univ, Grad Sch Med, Osaka 558, Japan

[9] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Leukemia, Hackensack, NJ USA

[10] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Internal Med, Kaohsiung, Taiwan

[11] Novartis Pharma AG, Oncol, Basel, Switzerland

[12] Royal Adelaide Hosp, Dept Haematol SA Pathol, Adelaide, SA 5000, Australia

[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：944 / 945

页数：2